Stem_technology

New biomedical technology to solve human factors problems.

The project is at the idea stage, although some countries are trying to implement it. 3D bioprinting is the process of creating cellular structures in a limited space using 3D printing technologies, which allows to preserve the function and viability of cells in the printed structure.

The average age of my clients is 70-75 years old, which is more than 71%.
There are people younger than 18 years old. But heart problems including (heart failure) are getting younger every year.

Heart disease kills more people every year than all forms of cancer combined.
Cardiovascular disease is the No. 1 cause of death in almost every developed country in the world. It causes 1 out of every 3 deaths worldwide.
In the U.S. alone, someone has a heart attack every 34 seconds.
Every 30 seconds someone dies of cardiovascular disease in the U.S.

Potentially it is possible to solve this problem with regeneration or tissue replacement or replacement of the entire organ, which is what I am doing .

Competitors Biolife4D and Bioscript (all U.S.-based companies)
There are no alternatives.

3D bioprinting is the process of creating cellular structures in a confined space using 3D printing technology, which preserves the function and viability of the cells in the printed structure. In other words, a 3D bioprinter is a highly specialized 3D printer designed to protect living cells during the printing process. Bioprinters are now able to create functional biological structures that can one day restore, maintain, improve and/or replace existing organ functions.

Profits from the development are possible only when this technology is implemented in medical practice (in 1-3.5 years).
The average price of a heart transplant in this way will be approximately
0.9 million USD to 1.5 million USD.
The average number of clients if implemented in 2022 will be 500,000 to 3,000,000 million people.

Key Metrics include the demand for the product and mortality (and because of the lack of that product) worldwide (added in photos).

I need investment in order to purchase the reagents and instruments
that I will need to successfully complete this project.

We'll voice it in the negotiation process.

Additional funding will be needed to implement this development into medical practice.